Novel sustained release formulation using collagen as a carrier material. (1)-dosage form design of interferon minipellet

Drug Delivery System

Volumn 11, Issue 3, 1996, Pages 175-181

  Maeda, Hiroo ^a   Ohtsuka, Takayuki ^a   Maeda, Miho ^a   Sasaki, Yoshio ^a   Sato, Shigeji ^a   Fujioka, Keiji ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

aterocollagen; dosage form design; interferon; minipellet; sustained release

Indexed keywords

EID: 0006906648     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.11.175     Document Type: Article

References (7)

1. Sanders, L.M. : Drug delivery systems and routes of administration of peptide and protein drugs. Eur. J. Drug Metab. and Pharmacokinet. 15 : 95-102, 1990.
2. Shim, C. K., Kim, S. R. : Administration route dependent bioavailability of interferon-α and effect of bile salts on the nasal absorption. Drug Development and Industrial Pharmacy 19 : 1183-1199, 1993.
3. Strenzel, K. H., Miyata, T., Rubin, A. L. : Collagen as a biomaterial. Annual review of Biophysics and Bioengineering 3 : 231-253, 1974.
4. Miller, J. M., Zoll, D. R., Brown, E. O. : Clinical observation on use of an extruded collagen suture. Arch. Surg. 88 : 167-174, 1964.
5. Kamer, F. M., Churukian M. M., : Clinical use of injectable collagen. Arch. Otolaryngol. 110 : 93-98, 1984.
6. Gilbert, D. L., Okano, T., Miyata, T., Kim, S. W. : Macromolecular diffusion through collagen membranes. Int. J. Pharm. 47 : 79-88, 1988.
7. Gilbert, D. L., Kim, S. W. : Macromolecular release from collagen monolithic devices. J. Biomed. Mater. Res. 24 : 1221-1239, 1990.